A detailed history of Royal Capital Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Royal Capital Wealth Management, LLC holds 10,017 shares of ABBV stock, worth $1.8 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
10,017
Previous 10,170 1.5%
Holding current value
$1.8 Million
Previous $1.74 Million 13.42%
% of portfolio
1.43%
Previous 1.34%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $25,067 - $30,497
-153 Reduced 1.5%
10,017 $1.98 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $13,002 - $15,183
-84 Reduced 0.82%
10,170 $1.74 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $10,388 - $11,836
-65 Reduced 0.63%
10,254 $1.87 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $8,531 - $9,608
-62 Reduced 0.6%
10,319 $1.6 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $18,435 - $21,341
-138 Reduced 1.31%
10,381 $1.55 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $18,153 - $22,591
-137 Reduced 1.29%
10,519 $1.42 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $10,990 - $12,657
-76 Reduced 0.71%
10,656 $1.7 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $968 - $1,161
7 Added 0.07%
10,732 $1.73 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $24,023 - $27,553
179 Added 1.7%
10,725 $1.44 Million
Q2 2022

Aug 16, 2022

BUY
$137.62 - $174.96 $1,513 - $1,924
11 Added 0.1%
10,546 $1.62 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $39,594 - $49,125
300 Added 2.93%
10,535 $1.71 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $1.1 Million - $1.39 Million
10,235 New
10,235 $1.39 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Royal Capital Wealth Management, LLC Portfolio

Follow Royal Capital Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Capital Wealth Management, LLC with notifications on news.